Status:

TERMINATED

Sinusitis and Facial Pain Disorders Anti-Depression Trial

Lead Sponsor:

University of Washington

Collaborating Sponsors:

National Institutes of Health (NIH)

Forest Laboratories

Conditions:

Chronic Sinusitis

Facial Pain Disorder

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The study hypothesis is that the addition of an antidepressant to the standard treatment regimen in patients with both chronic sinusitis and depression or facial pain disorders and depression will dec...

Detailed Description

All patients presenting to the University of Washington Medical Center Sinus Clinic are screened for depression with the PHQ-9 as a standard of care in their evaluation, as well as a physical examinat...

Eligibility Criteria

Inclusion

  • meet diagnostic criteria for chronic sinusitis
  • meet diagnostic criteria for facial pain disorder
  • meet criteria for major depressive disorder on the PHQ-9
  • 18 years of age or older
  • established primary care provider
  • able to read and speak English

Exclusion

  • unable to give informed consent of unable to complete self-administered questionnaires due to cognitive impairment, language barriers or severe medical condition
  • terminal illness or significantly immunocompromized
  • complications from chronic rhinosinusitis
  • presence of sinus tumor
  • isolated sphenoid disease
  • immotile cilia syndrome
  • currently on anti-depressant or mood stabilizer med.
  • diagnosis of bipolar disorder, schizophrenic disorders, paranoid disorders, or psychotic disorders NOS
  • significant suicide risk
  • history of hospitalization for mental disorders including psychosis or depression
  • history of drug abuse within prev. 6 months or dependency on any drug, including alcohol
  • pregnant or breast feeding
  • women of child-bearing potential not currently using an approved method of birth control

Key Trial Info

Start Date :

January 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2012

Estimated Enrollment :

3 Patients enrolled

Trial Details

Trial ID

NCT00754793

Start Date

January 1 2009

End Date

December 1 2012

Last Update

January 17 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Washington Medical Center

Seattle, Washington, United States, 98195